ArticleFrontiers in oncology2020

GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.